Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
From the Cover: Neutralization of terminal differentiation in gliomagenesis.
Hu J, Ho AL, Yuan L, Hu B, Hua S, Hwang SS, Zhang J, Hu T, Zheng H, Gan B, Wu G, Wang YA, Chin L, DePinho RA. Hu J, et al. Among authors: ho al. Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14520-7. doi: 10.1073/pnas.1308610110. Epub 2013 Aug 5. Proc Natl Acad Sci U S A. 2013. PMID: 23918370 Free PMC article.
[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
Backhaus P, Pentlow KS, Ho AL, Mauguen A, Fagin JA, Pillarsetty NVK, Lyashchenko SK, Burnazi E, Ghossein RA, Chhabra S, Abusamra M, Larson SM, Schöder H, O'Donoghue J, Weber W, Grewal RK. Backhaus P, et al. Among authors: ho al. EJNMMI Res. 2024 Oct 8;14(1):91. doi: 10.1186/s13550-024-01138-x. EJNMMI Res. 2024. PMID: 39377970 Free PMC article.
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.
Desilets A, Vos JL, Katabi N, Kuo F, Nadeem Z, Linxweiler M, Ostrovnaya I, Baxi S, Dunn LA, Sherman EJ, Pfister DG, Morris LGT, Ho AL. Desilets A, et al. Among authors: ho al. Clin Cancer Res. 2024 Dec 2;30(23):5281-5292. doi: 10.1158/1078-0432.CCR-24-1064. Clin Cancer Res. 2024. PMID: 39352719 Clinical Trial.
Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma.
Xu B, Baine MK, Jungbluth A, Alabkaa A, Serrette R, Roy D, Rudin CM, Ho AL, Sherman E, Dogan S, Ganly I, Rekhtman N, Ghossein R. Xu B, et al. Among authors: ho al. J Clin Endocrinol Metab. 2024 Sep 26:dgae672. doi: 10.1210/clinem/dgae672. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39324657
262 results